{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:58:18Z","timestamp":1762390698580},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1097\/mnm.0000000000000623","type":"journal-article","created":{"date-parts":[[2016,12,3]],"date-time":"2016-12-03T19:10:08Z","timestamp":1480792208000},"page":"170-177","source":"Crossref","is-referenced-by-count":15,"title":["The role of 68Ga-DOTA-NOC PET\/CT in evaluating neuroendocrine tumors"],"prefix":"10.1097","volume":"38","author":[{"given":"Mohamad","family":"Haidar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Shamseddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Panagiotidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Jreige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Mukherji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Assi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayan","family":"Abousaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toni","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwan M.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sobhan","family":"Vinjamuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210212","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0300-595X(80)80030-2","article-title":"The APUD concept and hormone production","volume":"9","author":"Pearse","year":"1980","journal-title":"Clin Endocrinol Metab"},{"key":"R2-11-20210212","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/0016-5085(93)91091-U","article-title":"Somatostatin-receptor imaging of human malignancies: a new era in the localization, staging, and treatment of tumors","volume":"105","author":"Kvols","year":"1993","journal-title":"Gastroenterology"},{"key":"R3-11-20210212","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/er.2002-0007","article-title":"Peptide receptors as molecular targets for cancer diagnosis and therapy","volume":"24","author":"Reubi","year":"2003","journal-title":"Endocr Rev"},{"key":"R4-11-20210212","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s002590100639","article-title":"Biokinetics and imaging with somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data","volume":"28","author":"Hofmann","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"R5-11-20210212","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1148\/radiology.150.2.6318260","article-title":"CT of pancreatic islet cell tumors","volume":"150","author":"Stark","year":"1984","journal-title":"Radiology"},{"key":"R6-11-20210212","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.gie.2010.08.030","article-title":"EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors","volume":"73","author":"Khashab","year":"2011","journal-title":"Gastrointest Endosc"},{"key":"R7-11-20210212","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0016-5085(87)90963-2","article-title":"Prospective study of the ability of computed axial tomography to localize gastrinomas in patients with Zollinger\u2013Ellison syndrome","volume":"92","author":"Wank","year":"1987","journal-title":"Gastroenterology"},{"key":"R8-11-20210212","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1259\/bjr.74.886.740968","article-title":"MRI of pancreatic neuroendocrine tumours","volume":"74","author":"Owen","year":"2001","journal-title":"Br J Radiol"},{"key":"R9-11-20210212","first-page":"41","article-title":"PET imaging in endocrine tumours","volume":"33","author":"Khan","year":"2008","journal-title":"Minerva Edocrinol"},{"key":"R10-11-20210212","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cpet.2013.08.008","article-title":"Role of 18F-fluorodeoxyglucose PET in the study of neuroendocrine tumors","volume":"9","author":"Panagiotidis","year":"2014","journal-title":"PET Clin"},{"key":"R11-11-20210212","first-page":"68","article-title":"Use of PET in neuroendocrine tumors: in vivo applications and in vitro studies","volume":"44","author":"Eriksson","year":"2000","journal-title":"Q J Nucl Med"},{"key":"R12-11-20210212","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1148\/radiology.212.1.r99jl3035","article-title":"Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-d-glucose PET","volume":"212","author":"Shulkin","year":"1999","journal-title":"Radiology"},{"key":"R13-11-20210212","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/107327480501200408","article-title":"Review of fluorine-18-fluro-2-deoxy-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomas","volume":"12","author":"Khan","year":"2005","journal-title":"Cancer Control"},{"key":"R14-11-20210212","first-page":"4087","article-title":"Gallium-68 PET: a new frontier in receptor cancer imaging","volume":"27","author":"Al-Nahhas","year":"2007","journal-title":"Anticancer Res"},{"key":"R15-11-20210212","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","article-title":"68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumours: comparison with somatostatin receptor scintigraphy and CT","volume":"48","author":"Gabriel","year":"2007","journal-title":"J Nucl Med"},{"key":"R16-11-20210212","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/SLA.0b013e3181fd37e8","article-title":"The impact of 68Ga-DOTATOC positron emission tomography\/computed tomography on the multimodal management of patients with neuroendocrine tumors","volume":"252","author":"Frilling","year":"2010","journal-title":"Ann Surg"},{"key":"R17-11-20210212","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0284185113496679","article-title":"Diagnostic role of gallium-68 DOTATOCand gallium-68 DOTATATE PET inpatients with neuroendocrine tumors: a meta-analysis","volume":"55","author":"Yang","year":"2014","journal-title":"Acta Radiol"},{"key":"R18-11-20210212","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1200\/JCO.2015.64.0987","article-title":"Prospective study of 68Ga-DOTATATE positron emission tomography\/computed tomography for detecting gastro-entero-pancreatic neuroendocrine tumors and unknown primary sites","volume":"34","author":"Sadowski","year":"2016","journal-title":"J Clin Oncol"},{"key":"R19-11-20210212","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.2967\/jnumed.111.101675","article-title":"The role of 68Ga-DOTATATE PET\/CT in suspected neuroendocrine tumors","volume":"53","author":"Haug","year":"2012","journal-title":"J Nucl Med"},{"key":"R20-11-20210212","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12020-012-9631-1","article-title":"Diagnostic performance of gallium-68 somatostatin receptor PET and PET\/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumors: a meta-analysis","volume":"42","author":"Treglia","year":"2012","journal-title":"Endocrine"},{"key":"R21-11-20210212","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2967\/jnumed.115.166017","article-title":"The impact of 68Ga-DOTATATE PET\/CT imaging on management of patients with neuroendocrine tumors: experience from a National Referral Center in the United Kingdom","volume":"57","author":"Skoura","year":"2016","journal-title":"J Nucl Med"},{"key":"R22-11-20210212","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2214\/AJR.11.7298","article-title":"Gallium-68-DOTA-NOC PET\/CT of patients with gastroenteropancreatic neuroendocrine tumors: a prospective single-center study","volume":"197","author":"Naswa","year":"2011","journal-title":"Am J Roentgenol"},{"key":"R23-11-20210212","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2967\/jnumed.109.069765","article-title":"Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET","volume":"51","author":"Binderup","year":"2010","journal-title":"J Nucl Med"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000000623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:35:13Z","timestamp":1620963313000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006231-201702000-00011"}},"subtitle":["real-world experience from two large neuroendocrine tumor centers"],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000000623","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}